Please wait while the formulary information is being retrieved.
HUMATIN (paromomycin sulfate)
- rapid onset of an intestinal infection due to amebae
- chronic intestinal infection caused by amebae
- unconsciousness resulting from liver cell deterioration
paromomycin 250 mg capsule
- 1 capsule (250 mg) by oral route 3 times per day
250 mg capsule
- 1 capsule (250 mg) by oral route 3 times per day
Acute intestinal amebiasis
- 8.33 mg/kg by oral route 3 times per day
- 8.33 mg/kg by oral route 3 times per day for 5 days
- 8.33 mg/kg by oral route 3 times per day for 7 days
- 8.33 mg/kg by oral route 3 times per day for 10 days
- 11.67 mg/kg by oral route 3 times per day for 10 days
- 11.67 mg/kg by oral route 3 times per day for 7 days
- 11.67 mg/kg by oral route 3 times per day for 5 days
- 11.67 mg/kg by oral route 3 times per day
- 1 capsule (250 mg) by oral route 3 times per day for 7 days
- 1 capsule (250 mg) by oral route 3 times per day for 10 days
- 1 capsule (250 mg) by oral route 3 times per day
- 2 capsules (500 mg) by oral route 3 times per day
- 2 capsules (500 mg) by oral route 3 times per day for 10 days
- 2 capsules (500 mg) by oral route 3 times per day for 7 days
Chronic intestinal amebiasis
- 8.33 mg/kg by oral route 3 times per day
- 8.33 mg/kg by oral route 3 times per day for 5 days
- 8.33 mg/kg by oral route 3 times per day for 7 days
- 8.33 mg/kg by oral route 3 times per day for 10 days
- 11.67 mg/kg by oral route 3 times per day for 10 days
- 11.67 mg/kg by oral route 3 times per day for 7 days
- 11.67 mg/kg by oral route 3 times per day for 5 days
- 11.67 mg/kg by oral route 3 times per day
- 1 capsule (250 mg) by oral route 3 times per day for 7 days
- 1 capsule (250 mg) by oral route 3 times per day for 10 days
- 1 capsule (250 mg) by oral route 3 times per day
- 2 capsules (500 mg) by oral route 3 times per day
- 2 capsules (500 mg) by oral route 3 times per day for 10 days
- 2 capsules (500 mg) by oral route 3 times per day for 7 days
Hepatic coma
- 4 capsules (1 gram) by oral route 4 times per day for 5 days
- 4 capsules (1 gram) by oral route 4 times per day for 6 days
- 8 capsules (2 gram) by oral route 2 times per day for 5 days
- 8 capsules (2 gram) by oral route 2 times per day for 6 days
- None
Contraindicated
- abobotulinumtoxinA
- Anectine
- atracurium
- Botox
- Botox Cosmetic
- cisatracurium
- Dysport
- incobotulinumtoxinA
- Myobloc
- Nimbex
- onabotulinumtoxinA
- pancuronium
- Quelicin
- rimabotulinumtoxinB
- rocuronium
- succinylcholine chloride
- vecuronium bromide
- Xeomin
- Zemuron
Severe
Moderate
- Cedax
- cefaclor
- cefadroxil
- cefazolin
- cefazolin in dextrose (iso-os)
- cefdinir
- cefepime
- cefepime in dextrose 5 %
- cefepime in dextrose,iso-osm
- cefotaxime
- cefotetan
- cefotetan in dextrose, iso-osm
- cefoxitin
- cefoxitin in dextrose 3.9 %
- cefoxitin in dextrose, iso-osm
- cefpodoxime
- cefprozil
- ceftazidime
- ceftazidime in D5W
- ceftazidime-dextrose (iso-osm)
- ceftibuten
- Ceftin
- ceftriaxone
- ceftriaxone in dextrose,iso-os
- cefuroxime axetil
- cefuroxime in sterile water
- cefuroxime sodium
- cefuroxime-dextrose (iso-osm)
- cephalexin
- Claforan
- Digox
- digoxin
- Fortaz
- Fortaz In Dextrose 5 %
- Keflex
- Lanoxin
- Maxipime
- Mefoxin In Dextrose (iso-osm)
- Rocephin
- Tazicef
- Zinacef
- Zinacef In Sterile Water
- Gastrointestinal obstruction
- Mt-RNr1 inc risk of aminoglycoside-induced hearing loss
Contraindicated
- Disorder of the vestibulocochlear nerve
- Gastrointestinal ulcer
Severe
Moderate
- Kidney disease with reduction in GFR
HUMATIN (paromomycin sulfate)
- rapid onset of an intestinal infection due to amebae
- chronic intestinal infection caused by amebae
- unconsciousness resulting from liver cell deterioration
- None
- None
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Diarrhea
- Nausea
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Paromomycin
- Severity Level:
2
- Additional Notes: Recomm treatment for g.lamblia,entamoeba histolytica,tapeworm inf in pregnancy
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Paromomycin
Excretion not expected, oral product not absorbed into systemic circulation
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Excretion not expected, oral product not absorbed into systemic circulation |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acute intestinal amebiasis | |
| A06.0 | Acute amebic dysentery |
| A06.2 | Amebic nondysenteric colitis |
| Chronic intestinal amebiasis | |
| A06.1 | Chronic intestinal amebiasis |
| Hepatic coma | |
| B15.0 | Hepatitis A with hepatic coma |
| B16.0 | Acute hepatitis B with delta-agent with hepatic coma |
| B16.2 | Acute hepatitis B without delta-agent with hepatic coma |
| B17.11 | Acute hepatitis C with hepatic coma |
| B19.0 | Unspecified viral hepatitis with hepatic coma |
| B19.11 | Unspecified viral hepatitis B with hepatic coma |
| B19.21 | Unspecified viral hepatitis C with hepatic coma |
| K70.41 | Alcoholic hepatic failure with coma |
| K71.11 | Toxic liver disease with hepatic necrosis, with coma |
| K72.01 | Acute and subacute hepatic failure with coma |
| K72.11 | Chronic hepatic failure with coma |
| K72.91 | Hepatic failure, unspecified with coma |
| K76.82 | Hepatic encephalopathy |
| 0-9 | A-Z |
|---|---|
| A06.0 | Acute amebic dysentery |
| A06.1 | Chronic intestinal amebiasis |
| A06.2 | Amebic nondysenteric colitis |
| B15.0 | Hepatitis A with hepatic coma |
| B16.0 | Acute hepatitis B with delta-agent with hepatic coma |
| B16.2 | Acute hepatitis B without delta-agent with hepatic coma |
| B17.11 | Acute hepatitis C with hepatic coma |
| B19.0 | Unspecified viral hepatitis with hepatic coma |
| B19.11 | Unspecified viral hepatitis B with hepatic coma |
| B19.21 | Unspecified viral hepatitis C with hepatic coma |
| K70.41 | Alcoholic hepatic failure with coma |
| K71.11 | Toxic liver disease with hepatic necrosis, with coma |
| K72.01 | Acute and subacute hepatic failure with coma |
| K72.11 | Chronic hepatic failure with coma |
| K72.91 | Hepatic failure, unspecified with coma |
| K76.82 | Hepatic encephalopathy |
Formulary Reference Tool